The meeting is talking about type 2 diabetes and the associated cardiovascular (CV) and renal diseases. It determines the risk factors; pathophysiology for type 2 diabetes and heart failure. It explains the clinical outcomes of empagliflozin in type 2 diabetes with cardiovascular and kidney diseases demonstrating its efficacy and safety. It also discusses the management recommended standards for type 2 diabetes; cardiovascular and kidney diseases.
Limitless Solutions is one of the leading Service Companies based in the UAE that was created by pairing the passion for Business, Events, Education, IT Solutions, Travel and Tourism and Innovation. We mainly operate from Dubai & Sharjah in the UAE, and we have an office in the Seychelles.
We bring fresh and unique approach to the IT & MICE industry. We are strategic event management partners. We understand that a properly executed Projects can be leveraged on to support organizations’ strategic vision by incorporating it into a company’s marketing plan.